BRAF and melanoma: Chemical meningitis has been also reported with intrathecal liposomal cytarabine.25 In this case, prompt identification of chemical meningitis after the firstdose in patient with BRAF-V600E-mutated melanoma leptomeningeal metastases allowedfor dose delay and reduction and subsequent tolerability of 15 additional injectionswith appropriate clinical and MRI enhancement response.